Sat, Apr
43 New Articles

CMS and DLA Piper Advise Ovoca Bio on Ivix Acquisition

CMS and DLA Piper Advise Ovoca Bio on Ivix Acquisition

  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

CMS Russia and DLA Piper have advised Dublin-based life sciences investor Ovoca Bio Plc on its acquisition of Russian drug development company Ivix.

According to CMS, the transaction represents a strategic move by Ovoca and an opportunity to tap into the unique potential of the global demand for novel reproductive health products. “Fueled by the creativity of its researchers and the funding provided by Ovoca, Ivix is looking to develop an effective medicinal product and, following completion of the required clinical trials, to put it on the Russian and other markets,” CMS reports.

Vladimir Zenin, CMS Partner, said that such “exciting move” is transformative for Ovoca and opens a whole new era for Ovoca’s shareholders and other investors.

Ovoca Bio was formerly a gold exploration and mine development company known as Ovoca Gold. In July 2018 the company changed its name to Ovoca Bio to reflect its new business focus. Now the company aims to become a market leader in the development and commercialization of novel pharmaceutical product candidates.

Following the acquisition of Ivix, Ovoca Bio will retain the right to acquire a further participation interest to be issued by Ivix for USD 2.04 million which would increase its overall participation interest in the charter capital of Ivix by 9.9 percent. Should Ovoca Bio exercise the option, it will hold approximately a 59.9 percent interest in the charter capital of Ivix.

The CMS team was led by Partner Vladimir Zenin, who was supported by Associates Mikhail Panferov, Vladislav Eltovskiy, and Nikolai Molostov.

The DLA Piper team was led by Moscow-based Corporate Partner Leo Batalov, assisted by Senior Associate Andrei Sheetkin.

Russian Knowledge Partner

Founded in 1993, Egorov Puginsky Afanasiev & Partners is the leading full-service law firm in the CIS with offices in Russia, Ukraine and Belarus and associated office in Cyprus.

We handle some of the largest and most complex and demanding transactions. We advise our clients in many areas of law, including: dispute resolution in Russia and abroad, International Arbitration and Litigation, M&A and Corporate, antitrust issues, criminal law, intellectual property, restructurings and insolvencies, international trade and customs, tax, real estate and construction, banking and finance, energy and natural resources, environmental and technical regulation, marine and transport law, pharmaceuticals and healthcare and others.

We combine high academic qualifications, internationally acknowledged moral and ethical values, senior partners' professional experience and practical abilities with the vigour and knowledge of younger attorneys, providing clients with reliable, first-class service according to both Russian and western standards through a flexible structure.

All News about, and Legal Analysis by, Egorov Puginsky Afanasiev & Partners can be found here.

Firm's website: www.epam.ru


Our Latest Issue